Skip to content

AARD AARD Cash ratio

Cash ratio at other companies

AbbVie logo
AbbVieABBV
0.2×+0.1×
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
0.8×+0.5×
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
0.6×-0.3×
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
3.5×-0.3×
Viking Therapeutics logo
Viking TherapeuticsVKTX
1.1×-0.8×
Arvinas logo
ArvinasARVN
0.8×+0.4×

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Calculated from AARD’s reported figures.

Based on the most recent quarter.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's cash ratio?
AARD (AARD) reported cash ratio of 5.4× in Q1 2026.
How has AARD's cash ratio changed year-over-year?
AARD's cash ratio increased by 21.3% year-over-year, from 4.4× to 5.4×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.